Akanda Corp(AKAN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 6 at 4:00 PM ET (Korea 11/7 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -110.84 | Insider Own | 9.3% | Shs Outstand | 2.6M | Perf Week | -19.22% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 2.4M | Perf Month | -52.8% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 0.02% | Short Float | 2.19% | Perf Quarter | -83.23% |
| Income | -0.05B | P/S | 3.35 | EPS this Y | - | Inst Trans | -62.23% | Short Ratio | 0.04 | Perf Half Y | -96.89% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -805.66% | Short Interest | 0.05M | Perf YTD | -91.84% |
| Book/sh | -19.37 | P/C | 2.91 | EPS past 3/5Y | 68.73% 31.61% | ROE | - | 52W High | -98.94% ($78.90) | Perf Year | -97.19% |
| Cash/sh | 0.29 | P/FCF | - | Sales past 3/5Y | -53.82% 162.72% | ROIC | - | 52W Low | 2.36% ($0.82) | Perf 3Y | -99.97% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -8.94% | Gross Margin | -234.12% | Volatility(W/M) | 13.87% 11.8% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 28.42 | Sales Y/Y TTM | 84.19% | Oper. Margin | -1290.25% | ATR (14) | 0.17 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.22 | EPS Q/Q | 74.55% | Profit Margin | -7691.5% | RSI (14) | 21.88 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.22 | Sales Q/Q | - | SMA20 | -25.33% ($1.12) | Beta | 14.14 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -61.41% ($2.18) | Rel Volume | 0.06 | Prev Close | $0.85 |
| Employees | 8 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -89.8% ($8.24) | Avg Volume(3M) | 1.34M | Price | $0.84 |
| IPO | 2022/3/15 | Option/Short | No/Yes | Trades | 383 | Volume | 79,352 | Change | -1.4% |
🌿 Akanda () is a micro-cap company that cultivates and distributes medical cannabis while also operating telecommunications infrastructure (cell towers and dark fiber) in Mexico. It supplies medical cannabis grown in Lesotho and Portugal to the medical cannabis markets in the UK and Germany, while expanding its business scope into Mexican cell tower and fiber optic operations through its subsidiary First Towers & Fiber.
Over the past 1 year, on the lower side
99% below its 1-year high.
Traded less than usual. That is 6% of its average volume.
AKAN has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $335. Peers typically go for $170.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -100.0%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.0%.
Tap to view numbers
It ranks #80 of 83 in the industry
Based on market cap of $2M.
FAQ
What kind of company is AKAN?
AKAN belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of AKAN?
The market cap of AKAN is approximately $2M, ranking 5,772 within its sector.
What is the 52-week high and low for AKAN?
AKAN has recorded a 52-week high of $78.90 and a low of $0.82.
